文献速递结核与非结核分枝杆菌

过表达内源性STING激动剂的卡介苗增强对肺结核的保护作用

Bacillus Calmette-Guérin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis.
PubMed 文献 · J Infect Dis · 2020-01-01

研究构建过表达内源性分枝杆菌二腺苷酸环化酶基因的重组卡介苗BCG-disA-OE,可释放高水平STING激动剂c-di-AMP。在24周豚鼠疫苗-结核分枝杆菌攻击模型中,与野生型BCG相比,BCG-disA-OE降低肺重28%(P < .05)、病理评分34%及肺部CFU 2.0 log10(P < .05)。

要点

  • BCG-disA-OE在体外小鼠巨噬细胞中诱导TNF-α、IL-6、IL-1β、IRF3和IFN-β水平显著强于野生型BCG。
  • 豚鼠模型中BCG-disA-OE较野生型BCG降低肺重28%、病理评分34%、肺部CFU 2.0 log10。
  • 结果支持开发BCG载体STING激动剂作为结核疫苗策略。

核心结论

  • 过表达STING激动剂c-di-AMP的重组BCG显著增强对肺结核和肺外结核的保护效力。

研究设计与样本

  • 研究构建过表达内源性分枝杆菌二腺苷酸环化酶基因的重组BCG(BCG-disA-OE),可释放高水平STING激动剂c-di-AMP。
  • 采用24周豚鼠疫苗接种-结核分枝杆菌攻击模型,比较BCG-disA-OE与野生型BCG的保护效力。
  • 测量指标包括肺重、病理评分和结核分枝杆菌器官CFU计数。

主要发现

  • 体外小鼠巨噬细胞中,BCG-disA-OE诱导的TNF-α、IL-6、IL-1β、IRF3和IFN-β水平显著强于野生型BCG。
  • 豚鼠体内,BCG-disA-OE较野生型BCG降低肺重28%(P < .05)。
  • BCG-disA-OE较野生型BCG降低病理评分34%。
  • BCG-disA-OE较野生型BCG降低肺部结核分枝杆菌CFU 2.0 log10(P < .05)。

临床怎么用

  • 提示经BCG载体递送STING激动剂可能成为增强结核疫苗保护效力的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stimulator of interferon genes (STING) is a key cytosolic receptor for small nucleotides and plays a key role in anticancer and antiviral immunity. Cyclic dinucleotide STING agonists may comprise a novel class of vaccine adjuvants capable of inducing cellular immune responses and protective efficacy against intracellular pathogens. METHODS: We generated a recombinant Bacillus Calmette-Guérin ([BCG] BCG-disA-OE) that overexpresses the endogenous mycobacterial diadenylate cyclase gene and releases high levels of the STING agonist bis-(3'-5')-cyclic dimeric adenosine monophosphate (c-di-AMP). We used a 24-week guinea pig vaccination-Mycobacterium tuberculosis (M.tb.) challenge model to test the protective efficacy of BCG-disA-OE versus wild-type BCG and measured lung weights, pathology scores, and M.tb. organ colony-forming unit (CFU) counts. RESULTS: BCG-disA-OE elicited significantly stronger tumor necrosis factor-α, interleukin (IL)-6, IL-1β, interferon (IFN) regulatory factor 3, and IFN-β levels than BCG-wild type (WT) in vitro in murine macrophages. In vivo in guinea pigs, we found that BCG-disA-OE reduced lung weights, pathology scores, and M.tb. CFU counts in lungs by 28% (P < .05), 34%, and 2.0 log10 CFU units (P < .05) compared with BCG-WT, respectively. CONCLUSIONS: We report a strategy of delivering a STING agonist from within live BCG. Overproduction of the STING agonist c-di-AMP significantly enhanced the protective efficacy of BCG against pulmonary and extrapulmonary tuberculosis. Our findings support the development of BCG-vectored STING agonists as a tuberculosis vaccine strategy.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Dey RJ, Dey B, Singh AK, et al. Bacillus Calmette-Guérin Overexpressing an Endogenous Stimulator of Interferon Genes Agonist Provides Enhanced Protection Against Pulmonary Tuberculosis. J Infect Dis. 2020. PMID: 30901058. doi:10.1093/infdis/jiz116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。